Mobia Medical, Inc. MOBI
12.20 USD -0.06 (-0.49%)
At closeNov 10, 2026, 4:00 PM EST
12.20 0.00 0.00%
After hours · Nov 10, 4:00 PM ET
11.79 Day range 12.78
8.03 52-week range 15.29
- YTD
- +3.83%
- 1 year
- +3.83%
News
marketbeat.com What Mobia Medical (MOBI) Said on Its Q3 Earnings Call Mobia Medical NASDAQ: MOBI raised its full-year revenue forecast after third-quarter sales rose 73%, driven by broader adoption of its Vivistim therapy at new and existing programs.
benzinga.com Sky-mobi Q3 2026 Earnings Call Transcript Sky-mobi (NASDAQ:MOBI) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.Benzinga APIs provide real-time…
benzinga.com Mobia Medical Raises FY2026 Sales Guidance from $54.000M-$56.000M to $57.000M-$57.500M vs $55.030M Est Mobia Medical (NASDAQ:MOBI) raises FY2026 sales outlook from $54.000 million-$56.000 million to $57.000 million-$57.500 million vs $55.030 million estimate.
globenewswire.com Mobia Medical to Participate in the 8th Annual Wolfe Research Healthcare Conference AUSTIN, Texas, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (Nasdaq: MOBI), a medical device company redefining stroke recovery for survivors living with life-altering motor impairments,…
benzinga.com Gap Posts Upbeat Q2 Earnings, Joins Solstice Advanced Materials, N-Able And Other Big Stocks Moving Higher On Friday U.S. stocks mixed, Nasdaq falls 0.1%. Gap Inc shares rise 15.2% on strong earnings and raised guidance. Other big gainers include Elastic NV, Solstice Advanced Materials Inc, and Pagerduty Inc.
benzinga.com JP Morgan Maintains Overweight on Mobia Medical, Raises Price Target to $17 JP Morgan analyst Robbie Marcus maintains Mobia Medical (NASDAQ:MOBI) with a Overweight and raises the price target from $15 to $17.- benzinga.com Mobia Medical Sees FY2026 Sales $54.000M-$56.000M vs $53.504M Est Mobia Medical (NASDAQ:MOBI) sees FY2026 sales of $54.000 million-$56.000 million vs $53.504 million analyst estimate.
benzinga.com Mobia Medical Q2 EPS $(1.10) Misses $(0.82) Estimate, Sales $13.505M Beat $12.380M Estimate Mobia Medical (NASDAQ:MOBI) reported quarterly losses of $(1.10) per share which missed the analyst consensus estimate of $(0.82) by 34.15 percent. The company reported quarterly sales of $13.505…
benzinga.com Mobia Medical Announces Publication Of 2-Yr Follow-Up Data From VNS-REHAB Study In Neurology, Official Peer-Reviewed Journal Of American Academy Of Neurology Mobia Medical, Inc. (NASDAQ:MOBI), a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments, today announced the publication of…- benzinga.com Mobia Medical Says CMS Proposes To Maintain Vivistim CPT Code 64568 Under New Technology APC 1580 With ~$45,000 Outpatient Payment Rate For 2027 Mobia Medical, Inc. (NASDAQ:MOBI), a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments, today announced that the Centers for…
benzinga.com This Oppenheimer Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday Wall Street analysts changed outlook on top names: ODTX, MOBI, MANE. See analyst ratings page for all changes. MOBI target prices: $16, $19, $31